Details
Category: Volume 07 Issue 10 October 2019
Hits: 904

Title: Relation between Vitamin D and Severity of Schizophrenia

Authors: Shashi Prabha, Pooja Nitin Joshi

 DOI: https://dx.doi.org/10.18535/jmscr/v7i10.146

Abstract

Introduction: Schizophrenia is a debilitating psychiatric disorder which is characterised by impairment of thinking, perception, affect and social behaviour. It is one of the leading causes of disability worldwide. The pathophysiology of schizophrenia includes dysregulation of multiple pathways. Vitamin D is implicated in neurodevelopmental origin of schizophrenia. Vitamin D level has been found to be low in patients with mental disorders including schizophrenia.

Objective: 1. To find serum Vitamin D levels in schizophrenic patients.2.To find correlation between Vitamin D level and disease severity based on Positive and Negative Syndrome Scale (PANSS) score.

Method: A Case-control study approved by Institutional Ethics Committee was conducted. The study included 30 cases of schizophrenia and 30 healthy controls based on inclusion and exclusion criteria.

Result: The mean age in years were 36.1 and 35.3 in the case group and control group respectively. The mean vitamin D level in the cases was 11.01+9.99 ng/ml and in controls was 18.51+ 5.61ng/ml. This difference was highly significant (p=<0.001).There was a weak negative correlation between vitamin D level in cases and PANSS score(r= -0.28).

Conclusion: Vitamin D levels were low in schizophrenic patients as compared to controls. A weak negative correlation was found between Vitamin D level and severity of disease based on PANSS score. Larger placebo control studies needs to be done to find out potential clinical benefits of Vitamin D supplementation in these patients.

Keywords: Vitamin D, schizophrenia, PANSS score

References

  1. Saha, D Chant, J Welham, J McGrath,” A systematic reviewof the prevalence of schizophrenia”, PLos Med., 2005 May;2(5):e141
  2. ICD-10 Classification of Mental and Behavioural Disorders
  3. C Deng, B Dean,” Mapping of pathophysiology of schizophrenia: interactions between multiple cellular pathways”, Front Cell Neurosci,  2013; 7: 238
  4. N Müller,” Inflammationin Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations”, Schizophr Bull, 2018 Aug; 44(5): 973–982
  5. D Eyles, F Feron, X Cui, J Kesby, L Harms, P Ko, J McGrath, T Burne,” Developmental vitamin D deficiency causes abnormal brain development”, Psychoneuroendocrinlogy, 2009 Dec;34 Suppl 1:S247-57
  6. M Wrzosek, J Łukaszkiewicz , M Wrzosek, A Jakubczyk , H Matsumoto , P Piątkiewicz , M Radziwoń-Zaleska , M Wojnar , G Nowicka ,” Vitamin D and the central nervous system”,Pharmacol Rep. 2013;65(2):271-8
  7. E Garcion, N Wion-Barbot , C Montero-Menei, F Berger , D Wion,”New clues about vitamin D functions in the nervous system”, Trends Endocrinol Metab, 2002, 13,100–105
  8. J Sonnenberg , V Luine , L Krey , S Christakos,”1,25 Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei”, Endocrinology, 1986, 118, 1433–1439
  9. F Féron, T Burne, J Brown, E Smith, J McGrath, A Mackay-Sim, D Eyles,” Developmental vitamin D3 deficiency alters the adult rat brain”, Brain Res Bull, 2005, 65, 141–148
  10. E Puchacz , W Stumpf , E Stachowiak , M Stachowiak,” Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells”, Brain Res Mol Brain Res, 1996, 36, 193–196
  11. C Lefebvre d’Hellencourt , C Montero-Menei, R Bernard, D Couez, “ Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line”, J Neurosci Res, 2003, 71, 575–582
  12. L Harms L, T Burne , D Eyles, J McGrath,”: Vitamin D and the brain”, Best Pract Res Clin Endocrinol Metab, 2011, 25, 657–669
  13. McGrath, T Burne, F Féron, A Mackay-Sim, DEyles, “Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update”, Schizophr Bull. 2010 Nov; 36(6): 1073–1078
  14. M Chiang, R Natrajan, X Fan,” Vitamin D in schizophrenia: a clinical review”, Evid Based Ment Health,2016 Feb;19(1):6-9
  15. Ana Dias Amaral , Conceição Calhau , Rui Coelho,” Schizophrenia: implications of vitamin D deficit on brain development”, International Journal of Clinical Neurosciences and Mental Health
  16. D Milovanovic,M Pirkovic, S Simonovic, M Matovic ,S Dejanovic, S Jankovic ,D Ravanic, M Petronijevic, D Risti ,V Mladenovic, M Jovanovic, S Labovic, M Pajovic ,D Djokovic, DPetrovic ,V Janjic ,”Parameters of Calcium Metabolism Fluctuated during Initiation or Changing of Antipsychotic Drugs” Psychiatry Investig, 2016 Jan; 13(1): 89–101
  17. B Samoes, C Silveira,” The Role of Vitamin D in the Pathophysiology of Schizophrenia”, Neuropsychiatry (2017) Volume 7, Issue 4
  18. G Valipour, P Saneei, A Esmaillzadeh,” Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies”, J Clin Endocrinol Metab2014 Oct;99(10):3863-72
  19. K Akinlade, O Olaniyan, V Lasebikan, S Rahamon, “Vitamin D Levels in Different Severity Groups of Schizophrenia”,Front Psychiatry, 2017 Jun 13;8:105

Corresponding Author

Shashi Prabha

Junior Resident, Department of Biochemistry, B.J. Government Medical College, Pune, Maharashtra, India-41100